drugset / Trial / NCT07163793
Pilot Study of Reduced Venetoclax Exposure
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Pilot Study of Reduced Venetoclax Exposure
Timeline
- Start
- 2025-08-26
- Primary completion
- 2026-10
- Completion
- 2028-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Venetoclax | Small molecule | 400 mg | — |
| Comparator | Azacitidine | Other / unclassified | — | — |
| Comparator | Decitabine | Small molecule | — | — |